Yifang Biotechnology (688382.SH) intends to launch a restricted stock incentive plan for 2025.
Yifang Biotechnology (688382.SH) disclosed the 2025 restricted stock incentive plan (draft), with a proposed grant of 5.577 million restricted stocks for incentive recipients, accounting for approximately 0.96% of the total share capital of the company as of the announcement date of the draft incentive plan. This grant is a one-time grant without any reserved rights. The incentive plan involves a total of 179 incentive recipients, with a grant price of 16.87 yuan per share.
Yifang Biological (688382.SH) disclosed the 2025 Restricted Stock Incentive Plan (draft), intending to grant 5.577 million restricted stocks to the incentive objects, accounting for approximately 0.96% of the total share capital of the company on the date of publication of the draft incentive plan. This grant is a one-time grant with no reserved rights. The incentive plan involves a total of 179 incentive objects, with a grant price of 16.87 yuan per share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


